Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Flitcroft

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
JAMA Ophthalmology|June 1, 2023
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.
Eye (London, England)|July 29, 2024
Correction: The long and short of it: a comprehensive assessment of axial length estimation in myopic eyes from ocular and demographic variablesGareth Lingham, James Loughman, Davoud Shariat Panah, et al.
Investigative Ophthalmology & Visual Science|March 1, 2019
IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic StudiesDaniel Ian Flitcroft, Mingguang He, Jost B Jonas, et al.
Journal of the Science of Food and Agriculture|July 30, 2013
Fate of Escherichia coli O157:H7 and Salmonella in soil and lettuce roots as affected by potential home gardening practicesMarilyn C Erickson, Jean Liao, Alison S Payton, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 8, 2026
Negligible Rebound in Myopia Progression Following Cessation of Treatment with 0.01% Atropine for 3 years: Year-4 Results from the CHAMP Phase 3 Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.
HRB Open Research|February 1, 2020
Myopia Outcome Study of Atropine in Children (MOSAIC): an investigator-led, double-masked, placebo-controlled, randomised clinical trial protocolSaoirse McCrann, Ian Flitcroft, Niall C Strang, et al.
Ophthalmology Science|December 24, 2025
MyopiaX-1 Safety and Efficacy of a Novel Approach to Slow Juvenile Myopia Progression: A Multicenter, Randomized, Controlled TrialJames Loughman, Gareth Lingham, Hakan Kaymak, et al.
Genes|April 23, 2022
Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration PopulationJulia Zhu, Kirk A J Stephenson, Adrian Dockery, et al.
Investigative Ophthalmology & Visual Science|June 12, 2025
Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended UsageIan Flitcroft, Mark A Bullimore, Kate L Gifford, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 31, 2025
Supplementation with high spatial frequency in visual environments for Chinese children to arrest myopia: A proof-of-concept exploratory studyWei Pan, Longbo Wen, Xin Yi, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
JAMA Ophthalmology|June 1, 2023
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.
Eye (London, England)|July 29, 2024
Correction: The long and short of it: a comprehensive assessment of axial length estimation in myopic eyes from ocular and demographic variablesGareth Lingham, James Loughman, Davoud Shariat Panah, et al.
Investigative Ophthalmology & Visual Science|March 1, 2019
IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic StudiesDaniel Ian Flitcroft, Mingguang He, Jost B Jonas, et al.
Journal of the Science of Food and Agriculture|July 30, 2013
Fate of Escherichia coli O157:H7 and Salmonella in soil and lettuce roots as affected by potential home gardening practicesMarilyn C Erickson, Jean Liao, Alison S Payton, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 8, 2026
Negligible Rebound in Myopia Progression Following Cessation of Treatment with 0.01% Atropine for 3 years: Year-4 Results from the CHAMP Phase 3 Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.
HRB Open Research|February 1, 2020
Myopia Outcome Study of Atropine in Children (MOSAIC): an investigator-led, double-masked, placebo-controlled, randomised clinical trial protocolSaoirse McCrann, Ian Flitcroft, Niall C Strang, et al.
Ophthalmology Science|December 24, 2025
MyopiaX-1 Safety and Efficacy of a Novel Approach to Slow Juvenile Myopia Progression: A Multicenter, Randomized, Controlled TrialJames Loughman, Gareth Lingham, Hakan Kaymak, et al.
Genes|April 23, 2022
Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration PopulationJulia Zhu, Kirk A J Stephenson, Adrian Dockery, et al.
Investigative Ophthalmology & Visual Science|June 12, 2025
Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended UsageIan Flitcroft, Mark A Bullimore, Kate L Gifford, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 31, 2025
Supplementation with high spatial frequency in visual environments for Chinese children to arrest myopia: A proof-of-concept exploratory studyWei Pan, Longbo Wen, Xin Yi, et al.
Pageof 9